- Home
- SGHT vs HOND Comparison
SGHT vs HOND Comparison
Compare SGHT & HOND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- HOND
- Stock Information
- Founded
- SGHT 2011
- HOND 2024
- Country
- SGHT United States
- HOND United States
- Employees
- SGHT N/A
- HOND N/A
- Industry
- SGHT Medical Specialities
- HOND
- Sector
- SGHT Health Care
- HOND
- Exchange
- SGHT Nasdaq
- HOND NYSE
- Market Cap
- SGHT 304.4M
- HOND 287.8M
- IPO Year
- SGHT 2021
- HOND 2024
- Fundamental
- Price
- SGHT $3.61
- HOND $10.01
- Analyst Decision
- SGHT Buy
- HOND
- Analyst Count
- SGHT 7
- HOND 0
- Target Price
- SGHT $6.27
- HOND N/A
- AVG Volume (30 Days)
- SGHT 206.9K
- HOND 1.1K
- Earning Date
- SGHT 11-07-2024
- HOND 01-01-0001
- Dividend Yield
- SGHT N/A
- HOND N/A
- EPS Growth
- SGHT N/A
- HOND N/A
- EPS
- SGHT N/A
- HOND N/A
- Revenue
- SGHT $79,543,000.00
- HOND N/A
- Revenue This Year
- SGHT $2.13
- HOND N/A
- Revenue Next Year
- SGHT $7.99
- HOND N/A
- P/E Ratio
- SGHT N/A
- HOND N/A
- Revenue Growth
- SGHT N/A
- HOND N/A
- 52 Week Low
- SGHT $3.30
- HOND $9.97
- 52 Week High
- SGHT $8.45
- HOND $11.57
- Technical
- Relative Strength Index (RSI)
- SGHT 41.47
- HOND N/A
- Support Level
- SGHT $3.45
- HOND N/A
- Resistance Level
- SGHT $3.64
- HOND N/A
- Average True Range (ATR)
- SGHT 0.19
- HOND 0.00
- MACD
- SGHT 0.03
- HOND 0.00
- Stochastic Oscillator
- SGHT 38.04
- HOND 0.00
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About HOND HCM II ACQUISITION CORP
HCM II Acquisition Corp is a blank check company.